Almujtama Alraida Medical Co (SAU:9592) 14-Day RSI: 28.77 (As of Sep. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:9592 Almujtama Alraida Medical Co SAU:9592
31 GF Score
Price ﷼20.65
GF Value ﷼29.81
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Almujtama Alraida Medical Co 14-Day RSI?

Almujtama Alraida Medical Co SAU:9592 31 14-Day RSI is 28.77 as of Sep. 13, 2026. GuruFocus rates SAU:9592 with a GF Score™ of 31/100 and a GF Value™ of ﷼29.81 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 700 Healthcare Providers & Services companies, Almujtama Alraida Medical Co ranks better than 92.57% on this metric.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2026-09-13), Almujtama Alraida Medical Co's 14-Day RSI is 28.77.

The industry rank for Almujtama Alraida Medical Co's 14-Day RSI or its related term are showing as below:

SAU:9592's 14-Day RSI is ranked better than
92.57% of 700 companies
in the Healthcare Providers & Services industry
Industry Median: 46.61 vs SAU:9592: 28.77

Almujtama Alraida Medical Co  (SAU:9592) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Almujtama Alraida Medical Co 14-Day RSI Related Terms


Almujtama Alraida Medical Co 14-Day RSI Competitor Comparison

For the Pharmaceutical Retailers subindustry, Almujtama Alraida Medical Co's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Almujtama Alraida Medical Co 14-Day RSI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Almujtama Alraida Medical Co's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Almujtama Alraida Medical Co's 14-Day RSI falls into.


SAU:9592
31GF Score
Almujtama Alraida Medical Co SAU:9592
14-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Almujtama Alraida Medical Co  (SAU:9592) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 14-Day RSI →
What does a 14-Day RSI of 28.77 mean?
Almujtama Alraida Medical Co (SAU:9592) has a 14-Day RSI of 28.77 as of Sep. 13, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Almujtama Alraida Medical Co and its competitors. According to the industry distribution chart, Almujtama Alraida Medical Co ranks #52 out of 700 companies in the Healthcare Providers & Services industry, placing it in the top 7.4%.
Is Almujtama Alraida Medical Co's 14-Day RSI too high?
Almujtama Alraida Medical Co's current 14-Day RSI is 28.77. The Healthcare Providers & Services industry median 14-Day RSI is 46.61. Almujtama Alraida Medical Co's value of 28.77 is 38.3% below this industry median. Based on the distribution chart, Almujtama Alraida Medical Co ranks #52 out of 700 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Almujtama Alraida Medical Co has a GF Score™ of 31/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Almujtama Alraida Medical Co's 14-Day RSI compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Almujtama Alraida Medical Co ranks #52 out of 700 companies for 14-Day RSI. This places Almujtama Alraida Medical Co in the top 7% of its industry — outperforming the majority of peers. The industry median 14-Day RSI is 46.61. Almujtama Alraida Medical Co's value of 28.77 is 38.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Healthcare Providers & Services company?
The median 14-Day RSI among Healthcare Providers & Services companies is 46.61, based on 700 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Almujtama Alraida Medical Co's current 14-Day RSI of 28.77 is 38.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Almujtama Alraida Medical Co and its competitors. For the Healthcare Providers & Services industry, the median 14-Day RSI is 46.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Almujtama Alraida Medical Co's current 14-Day RSI is 28.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almujtama Alraida Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Almujtama Alraida Medical Co (SAU:9592) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼29.81, compared to a current price of ﷼20.65 — trading 30.7% below its estimated fair value. The current 14-Day RSI is 28.77 and 38.3% below the Healthcare Providers & Services industry median of 46.61. Almujtama Alraida Medical Co's overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Almujtama Alraida Medical Co (SAU:9592), the current 14-Day RSI is 28.77 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Almujtama Alraida Medical Co (SAU:9592) Overvalued in 2026?

Based on GuruFocus' analysis, Almujtama Alraida Medical Co stock appears to be undervalued. The current stock price of ﷼20.65 is trading 30.7% below its estimated GF Value™ of ﷼29.81. GuruFocus considers Almujtama Alraida Medical Co to be Possible Value Trap.

Key valuation signals for SAU:9592:

  • 14-Day RSI: 28.77
  • GF Value™: ﷼29.81 vs. price of ﷼20.65 (30.7% below fair value)
  • GF Score™: 31/100 with 3 warning signs
  • Industry Position: 38.3% below the Healthcare Providers & Services median (#52 of 700)

No single metric tells the full story. See the SAU:9592 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Almujtama Alraida Medical Co Business Description

Address Main Street, P.O. Box 109474, Al-Hamadania District, Jeddah, SAU, 21351
Almujtama Alraida Medical Co is a company having its core operations include operating pharmacies and retailing pharmaceutical products such as medicines and cosmetic products and medical equipment and medical supplies. It also provides pharmaceutical services in the Kingdom of Saudi Arabia.
31GF Score

Get the complete analysis for SAU:9592

14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼20.65
Price
﷼29.81
GF Value